Loomis, Sayles & Company’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-45
| Closed | -$5K | – | 982 |
|
|
2023
Q2 | $5K | Sell |
45
-92
| -67% | -$10.2K | ﹤0.01% | 851 |
|
|
2023
Q1 | $21K | Buy |
137
+87
| +174% | +$13.3K | ﹤0.01% | 730 |
|
|
2022
Q4 | $9K | Sell |
50
-861
| -95% | -$155K | ﹤0.01% | 795 |
|
|
2022
Q3 | $108K | Buy |
911
+885
| +3,404% | +$105K | ﹤0.01% | 514 |
|
|
2022
Q2 | $4K | Hold |
26
| – | – | ﹤0.01% | 747 |
|
|
2022
Q1 | $4K | Sell |
26
-725
| -97% | -$112K | ﹤0.01% | 818 |
|
|
2021
Q4 | $191K | Buy |
751
+239
| +47% | +$60.8K | ﹤0.01% | 555 |
|
|
2021
Q3 | $197K | Sell |
512
-306
| -37% | -$118K | ﹤0.01% | 522 |
|
|
2021
Q2 | $192K | Sell |
818
-68
| -8% | -$16K | ﹤0.01% | 522 |
|
|
2021
Q1 | $116K | Buy |
886
+702
| +382% | +$91.9K | ﹤0.01% | 548 |
|
|
2020
Q4 | $19K | Buy |
+184
| New | +$19K | ﹤0.01% | 628 |
|